Vascular resistance of central retinal artery is reduced in postmenopausal women after use of estrogen.

Trial Profile

Vascular resistance of central retinal artery is reduced in postmenopausal women after use of estrogen.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2012

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Menopausal syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top